Cognitive Dysfunction in Chronic Fatigue Syndrome: a Review of Recent Evidence.

Erin Cvejic, Rachael C Birch, Uté Vollmer-Conna
Author Information
  1. Erin Cvejic: School of Psychiatry, University of New South Wales Medicine, Sydney, 2052, NSW, Australia.
  2. Rachael C Birch: School of Psychiatry, University of New South Wales Medicine, Sydney, 2052, NSW, Australia.
  3. Uté Vollmer-Conna: School of Psychiatry, University of New South Wales Medicine, Sydney, 2052, NSW, Australia. ute@unsw.edu.au.

Abstract

Cognitive difficulties represent a common and debilitating feature of the enigmatic chronic fatigue syndrome (CFS). These difficulties manifest as self-reported problems with attention, memory, and concentration and present objectively as slowed information processing speed particularly on complex tasks requiring sustained attention. The mechanisms underlying cognitive dysfunction remain to be established; however, alterations in autonomic nervous system activity and cerebral blood flow have been proposed as possibilities. Heterogeneity in the experience of cognitive impairment, as well as differences in the methods utilised to quantify dysfunction, may contribute to the difficulties in establishing plausible biological underpinnings. The development of a brief neurocognitive battery specifically tailored to CFS and adoption by the international research community would be beneficial in establishing a profile of cognitive dysfunction. This could also provide better insights into the underlying biological mechanisms of cognitive dysfunction in CFS and enhance the development of targeted treatments.

Keywords

References

  1. Neuroimage. 2005 Jun;26(2):513-24 [PMID: 15907308]
  2. Curr Psychiatry Rep. 2013 Apr;15(4):353 [PMID: 23440559]
  3. Psychol Med. 2010 Aug;40(8):1253-67 [PMID: 20047703]
  4. Neuropsychol Rev. 1996 Mar;6(1):47-60 [PMID: 9144668]
  5. Nat Rev Neurosci. 2011 Jul 27;12(9):539-44 [PMID: 21792218]
  6. Neuropsychology. 2014 May;28(3):394-405 [PMID: 24364389]
  7. Aust N Z J Psychiatry. 2001 Aug;35(4):520-7 [PMID: 11531735]
  8. J Psychosom Res. 2014 Apr;76(4):339 [PMID: 24630187]
  9. Qual Life Res. 2014 Nov;23(9):2407-16 [PMID: 24791749]
  10. Semin Arthritis Rheum. 2013 Oct;43(2):279-87 [PMID: 23838093]
  11. Ciba Found Symp. 1993;173:43-54; discussion 54-61 [PMID: 8491106]
  12. J Rehabil Res Dev. 2013;50(6):795-810 [PMID: 24203542]
  13. Neuroimage Clin. 2015 Sep 10;9:355-68 [PMID: 26594619]
  14. Magn Reson Imaging. 2016 May;34(4):603-8 [PMID: 26708036]
  15. Pain Physician. 2015 Sep-Oct;18(5):E841-52 [PMID: 26431138]
  16. J Rehabil Med. 2015 Aug 18;47(7):665-8 [PMID: 26035692]
  17. Ann Intern Med. 1994 Dec 15;121(12):953-9 [PMID: 7978722]
  18. PLoS One. 2012;7(12):e51515 [PMID: 23240035]
  19. J Psychosom Res. 2015 Dec;79(6):537-49 [PMID: 26359713]
  20. Qual Life Res. 2016 May;25(5):1257-63 [PMID: 26471263]
  21. Front Physiol. 2013 May 16;4:113 [PMID: 23720636]
  22. J Clin Exp Neuropsychol. 2012;34(7):679-87 [PMID: 22440059]
  23. Am J Physiol Heart Circ Physiol. 2012 Mar 1;302(5):H1185-94 [PMID: 22180650]
  24. Acta Psychiatr Scand. 2001 Feb;103(2):84-93 [PMID: 11167310]
  25. J Cogn Neurosci. 2002 Apr 1;14(3):340-7 [PMID: 11970796]
  26. Psychother Psychosom. 2011;80(6):353-8 [PMID: 21829047]
  27. Clin Sci (Lond). 2012 Mar;122(5):227-38 [PMID: 21919887]
  28. Psychol Med. 2013 Oct;43(10):2227-35 [PMID: 23363640]
  29. Clin Rheumatol. 2013 Oct;32(10):1475-85 [PMID: 23737111]
  30. Psychol Res Behav Manag. 2014 Feb 25;7:67-76 [PMID: 24596470]
  31. BJPsych Bull. 2015 Feb;39(1):24-7 [PMID: 26191420]
  32. Phys Ther. 2014 Apr;94(4):511-22 [PMID: 24363336]
  33. J Psychosom Res. 2013 Sep;75(3):242-8 [PMID: 23972413]
  34. Psychol Med. 1997 Jan;27(1):81-90 [PMID: 9122311]
  35. Arch Intern Med. 1999 Oct 11;159(18):2129-37 [PMID: 10527290]
  36. BMJ. 2015 May 05;350:h2087 [PMID: 25944462]
  37. J Neuropsychol. 2015 Mar;9(1):1-9 [PMID: 24112872]
  38. J Appl Physiol (1985). 2014 Nov 15;117(10):1157-64 [PMID: 25277740]
  39. Neuropsychology. 2013 Mar;27(2):230-42 [PMID: 23527651]
  40. Cochrane Database Syst Rev. 2015 Feb 10;(2):CD003200 [PMID: 25674924]
  41. Br J Clin Psychol. 1993 Sep;32 ( Pt 3):357-64 [PMID: 8251968]
  42. J Nucl Med. 2014 Jun;55(6):945-50 [PMID: 24665088]
  43. J Intern Med. 2011 Oct;270(4):327-38 [PMID: 21777306]
  44. Neuroimage. 2007 May 15;36(1):108-22 [PMID: 17408973]
  45. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):431-4 [PMID: 9576531]
  46. Arthritis Rheum. 1990 Feb;33(2):160-72 [PMID: 2306288]
  47. Lancet. 2011 Mar 5;377(9768):823-36 [PMID: 21334061]
  48. Curr Rheumatol Rep. 2006 Dec;8(6):425-9 [PMID: 17092441]
  49. Pharmacogenomics. 2006 Apr;7(3):355-64 [PMID: 16610946]
  50. Pharmacogenomics. 2006 Apr;7(3):365-73 [PMID: 16610947]
  51. Br J Psychiatry. 1997 Oct;171:377-81 [PMID: 9373430]
  52. Eur J Appl Physiol. 2014 Sep;114(9):1841-51 [PMID: 24878689]
  53. Eur J Clin Invest. 2014 May;44(5):516-26 [PMID: 24601948]
  54. PLoS One. 2015 Jan 09;10(1):e0117136 [PMID: 25575044]
  55. BMC Health Serv Res. 2003 Dec 31;3(1):25 [PMID: 14702202]
  56. Psychiatry Res. 2013 May 15;207(1-2):127-33 [PMID: 23062791]
  57. J Neurol Neurosurg Psychiatry. 1996 May;60(5):474-7 [PMID: 8778249]
  58. PLoS One. 2012;7(11):e49518 [PMID: 23166694]
  59. Behav Res Ther. 2014 Jan;52:9-16 [PMID: 24262484]
  60. Front Physiol. 2013 Apr 05;4:63 [PMID: 23576989]
  61. Popul Health Metr. 2009 Oct 05;7:17 [PMID: 19804639]
  62. Psychosom Med. 2006 Nov-Dec;68(6):947-55 [PMID: 17079703]
  63. Clin Rheumatol. 2016 Jan;35(1):191-203 [PMID: 25308475]

MeSH Term

Attention
Cognition Disorders
Cognitive Dysfunction
Fatigue Syndrome, Chronic
Humans
Memory

Word Cloud

Created with Highcharts 10.0.0cognitivedysfunctionCognitivedifficultiesCFSfatiguesyndromeattentionspeedmechanismsunderlyingestablishingbiologicaldevelopmentChronicFatiguerepresentcommondebilitatingfeatureenigmaticchronicmanifestself-reportedproblemsmemoryconcentrationpresentobjectivelyslowedinformationprocessingparticularlycomplextasksrequiringsustainedremainestablishedhoweveralterationsautonomicnervoussystemactivitycerebralbloodflowproposedpossibilitiesHeterogeneityexperienceimpairmentwelldifferencesmethodsutilisedquantifymaycontributeplausibleunderpinningsbriefneurocognitivebatteryspecificallytailoredadoptioninternationalresearchcommunitybeneficialprofilealsoprovidebetterinsightsenhancetargetedtreatmentsDysfunctionSyndrome:ReviewRecentEvidenceperformanceExecutivefunctioningNeurocognitionResponse

Similar Articles

Cited By